Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NVST
Upturn stock ratingUpturn stock rating

Envista Holdings Corp (NVST)

Upturn stock ratingUpturn stock rating
$19.54
Last Close (24-hour delay)
Profit since last BUY5%
upturn advisory
Consider higher Upturn Star rating
BUY since 33 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: NVST (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

14 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $19.04

1 Year Target Price $19.04

Analysts Price Target For last 52 week
$19.04Target price
Low$14.22
Current$19.54
high$23

Analysis of Past Performance

Type Stock
Historic Profit -20.37%
Avg. Invested days 29
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.33B USD
Price to earnings Ratio -
1Y Target Price 19.04
Price to earnings Ratio -
1Y Target Price 19.04
Volume (30-day avg) 14
Beta 1
52 Weeks Range 14.22 - 23.00
Updated Date 06/30/2025
52 Weeks Range 14.22 - 23.00
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -6.54

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -44.9%
Operating Margin (TTM) 7.99%

Management Effectiveness

Return on Assets (TTM) 1.57%
Return on Equity (TTM) -31.33%

Valuation

Trailing PE -
Forward PE 19.68
Enterprise Value 3817009545
Price to Sales(TTM) 1.33
Enterprise Value 3817009545
Price to Sales(TTM) 1.33
Enterprise Value to Revenue 1.52
Enterprise Value to EBITDA 24.09
Shares Outstanding 169487008
Shares Floating 168902283
Shares Outstanding 169487008
Shares Floating 168902283
Percent Insiders 0.54
Percent Institutions 117.39

Analyst Ratings

Rating 4
Target Price 19.04
Buy -
Strong Buy 3
Buy -
Strong Buy 3
Hold 10
Sell -
Strong Sell 1
Strong Sell 1

ai summary icon Upturn AI SWOT

Envista Holdings Corp

stock logo

Company Overview

overview logo History and Background

Envista Holdings Corp. was formed in 2019 when Danaher Corporation spun off its dental business. Danaher had been building its dental portfolio for decades through numerous acquisitions, establishing a leading position in the dental industry.

business area logo Core Business Areas

  • Specialty Products & Technologies: This segment encompasses a diverse range of products used by dental professionals, including implants, orthodontics (braces and aligners), and related equipment and supplies.
  • Equipment & Consumables: This segment includes dental equipment such as imaging systems, handpieces, and consumables like restoratives, cements, and infection control products.

leadership logo Leadership and Structure

Amir Aghdaei serves as the Chief Executive Officer. The company operates with a decentralized structure, empowering individual business units while leveraging shared resources and expertise across the organization. Envista Holdings Corp. is listed on the New York Stock Exchange under the symbol NVST.

Top Products and Market Share

overview logo Key Offerings

  • Nobel Biocare (Implants): Nobel Biocare is a leading brand in dental implants, offering a comprehensive range of implant systems and related products. It has a significant market share in the global dental implant market, estimated to be around 18%. Competitors include Straumann, Danaher's (DHR) KaVo Kerr, and Dentsply Sirona (XRAY).
  • Ormco (Orthodontics): Ormco is a major player in orthodontics, providing braces, aligners (Spark Clear Aligners) and related products. The Invisalign brand of Align Technology (ALGN) is a major competitor, along with others such as 3M Unitek.
  • KaVo Kerr (Equipment & Consumables): KaVo Kerr manufactures a variety of dental equipment and consumables, with products ranging from X-ray machines to handpieces and dental filling materials. Other competitors include Planmeca and Dentsply Sirona (XRAY).

Market Dynamics

industry overview logo Industry Overview

The dental industry is characterized by steady growth, driven by factors such as an aging population, increasing awareness of oral health, and rising disposable incomes. Digital dentistry, including CAD/CAM systems and 3D printing, is transforming the industry. However, it is also sensitive to consumer spending and economic downturns.

Positioning

Envista Holdings Corp. holds a leading position in the dental industry, with a strong portfolio of established brands and a diversified product offering. Its competitive advantages include its global reach, strong distribution network, and focus on innovation.

Total Addressable Market (TAM)

The global dental market is estimated to be around $40-50 billion. Envista Holdings Corp. is positioned well to capture a significant share of this market due to its diverse portfolio and global presence.

Upturn SWOT Analysis

Strengths

  • Strong Brand Portfolio
  • Global Presence
  • Extensive Distribution Network
  • Focus on Innovation
  • Recurring Revenue Streams (consumables)
  • Experienced Management Team

Weaknesses

  • Exposure to Economic Cycles
  • Integration Risks from Acquisitions
  • Dependence on Key Brands
  • Higher levels of debt from spin-off
  • Spark Clear Aligners lagging against Invisalign in the Orthodontics market

Opportunities

  • Growth in Emerging Markets
  • Expansion in Digital Dentistry
  • Increasing Demand for Cosmetic Dentistry
  • Strategic Acquisitions
  • Partnerships with dental professionals

Threats

  • Intense Competition
  • Technological Disruption
  • Changing Regulatory Landscape
  • Economic Downturn
  • Pricing Pressures

Competitors and Market Share

competitor logo Key Competitors

  • XRAY
  • ALGN
  • DHR

Competitive Landscape

Envista possesses strengths in equipment, consumables, and implants while competitors have better positions in orthodontics and digital dentistry. Envista's decentralized structure offers flexibility but may lack synergy.

Major Acquisitions

Carestream Dental Intraoral Scanners

  • Year: 2024
  • Acquisition Price (USD millions): 600
  • Strategic Rationale: This acquisition strengthens Envista's position in the digital dentistry market, providing a comprehensive portfolio of intraoral scanning solutions. It allows Envista to broaden its offering and integrate this with its existing product line, thus creating more customer value.

OsteoReady

  • Year: 2024
  • Acquisition Price (USD millions): 75
  • Strategic Rationale: This acquisition increases Envista's market share in bone regeneration materials, enabling the company to provide comprehensive solutions for its dental implant customers.

Growth Trajectory and Initiatives

Historical Growth: Envista's growth has been driven by organic growth, new products, and acquisitions. A sample of historical growth values is: Organic Growth [%]: [5.6, 5.8, 3.0]

Future Projections: Analysts estimate continued growth, driven by increasing demand for dental products and services, especially in emerging markets. Requires analysis of analyst estimates and guidance.

Recent Initiatives: Recent initiatives include investments in digital dentistry solutions, product development, and strategic acquisitions to expand market share.

Summary

Envista Holdings Corp. is a key player in the dental industry. It has a strong portfolio and global reach. Challenges remain regarding integration efforts of acquired assets. Competition, especially in orthodontics, require monitoring as well as potential new regulatory and compliance standards which could affect pricing.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings (Annual Reports, Investor Presentations), Analyst Reports (e.g., from major investment banks), Market Research Reports (e.g., from industry-specific firms), Press Releases

Disclaimers:

This analysis is based on publicly available information and represents a general overview. Investment decisions should be based on thorough research and consultation with a financial advisor. Market conditions and company performance are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Envista Holdings Corp

Exchange NYSE
Headquaters Brea, CA, United States
IPO Launch date 2019-09-18
CEO & Director Mr. Paul A. Keel
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 12300
Full time employees 12300

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.